137 related articles for article (PubMed ID: 34967358)
1. Successful fluconazole combined with caspofungin treatment of candida bloodstream infection in preterm infant: A case report.
Yuan G; Tu Y; Liu L; Xu T
Medicine (Baltimore); 2021 Dec; 100(52):e28270. PubMed ID: 34967358
[TBL] [Abstract][Full Text] [Related]
2. Successful caspofungin treatment of persistent candidemia in extreme prematurity at 23 and 24 weeks' gestation.
Jeon GW; Sin JB
J Formos Med Assoc; 2014 Mar; 113(3):191-4. PubMed ID: 24534016
[TBL] [Abstract][Full Text] [Related]
3. Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015.
Liu Y; Kang M; Ye H; Zong Z; Lv X
J Mycol Med; 2018 Mar; 28(1):222-226. PubMed ID: 29254811
[TBL] [Abstract][Full Text] [Related]
4. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Lindberg E; Hammarström H; Ataollahy N; Kondori N
Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Comparison of simulated candidemia detection during prophylactic antifungal therapy.
Lim YK; Kweon OJ; Kim HR; Kim TH; Lee MK
Diagn Microbiol Infect Dis; 2022 Oct; 104(2):115768. PubMed ID: 35944341
[TBL] [Abstract][Full Text] [Related]
7. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
8. Fungicidal activity and PK/PD of caspofungin as tools to guide antifungal therapy in a fluconazole-resistant C. parapsilosis candidemia.
Tascini C; Sozio E; Di Paolo A; Tintori G; Leonildi A; Bertolino G; Carmassi F; Tagliaferri E; Menichetti F; Barchiesi F
J Chemother; 2017 Dec; 29(6):376-379. PubMed ID: 28198656
[TBL] [Abstract][Full Text] [Related]
9. Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.
Al-Sweih N; Ahmad S; Joseph L; Khan S; Vayalil S; Chandy R; Khan Z
J Clin Microbiol; 2015 Mar; 53(3):1038-41. PubMed ID: 25568433
[TBL] [Abstract][Full Text] [Related]
10. Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients.
Lortholary O; Desnos-Ollivier M; Sitbon K; Fontanet A; Bretagne S; Dromer F;
Antimicrob Agents Chemother; 2011 Feb; 55(2):532-8. PubMed ID: 21078946
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and antifungal susceptibility patterns of candidemia from a tertiary centre in Western Australia.
Boan P; Gardam D
J Chemother; 2019 May; 31(3):137-140. PubMed ID: 30955472
[TBL] [Abstract][Full Text] [Related]
12. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with fluconazole resistance in Candida parapsilosis candidemia: A case-case study.
Atalay S; Çağlayan D; Arkalı E; Sönmez U; Şamlıoğlu P
Mycoses; 2024 Mar; 67(3):e13717. PubMed ID: 38544313
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients.
Zhang W; Song X; Wu H; Zheng R
BMC Infect Dis; 2020 Jul; 20(1):506. PubMed ID: 32660641
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality.
Vannini M; Emery S; Lieutier-Colas F; Legueult K; Mondain V; Retur N; Gastaud L; Pomares C; Hasseine L
J Mycol Med; 2022 Mar; 32(1):101210. PubMed ID: 34768155
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
Sellami A; Sellami H; Néji S; Makni F; Abbes S; Cheikhrouhou F; Chelly H; Bouaziz M; Hammami B; Ben Jemaa M; Khaled S; Ayadi A
Mycopathologia; 2011 Jun; 171(6):417-22. PubMed ID: 21170738
[TBL] [Abstract][Full Text] [Related]
18. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy.
Zhang L; Xiao M; Watts MR; Wang H; Fan X; Kong F; Xu YC
BMC Infect Dis; 2015 Aug; 15():340. PubMed ID: 26282840
[TBL] [Abstract][Full Text] [Related]
19. Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients.
Hilmioğlu-Polat S; Sharifynia S; Öz Y; Aslan M; Gündoğdu N; Serin A; Rafati H; Mohammadi F; Yeşim-Metin D; Döğen A; Ilkit M; Seyedmousavi S
Mycopathologia; 2018 Aug; 183(4):701-708. PubMed ID: 29725811
[TBL] [Abstract][Full Text] [Related]
20.
Aboutalebian S; Nikmanesh B; Mohammadpour M; Charsizadeh A; Mirhendi H
Front Cell Infect Microbiol; 2023; 13():1277607. PubMed ID: 38029248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
